Lisa Chaiken
YOU?
Author Swipe
View article: RADT-11. HIGH INCIDENCE AND OUTCOME OF MULTICENTRIC HIGH GRADE GLIOMA (MCHGG) COMPARED TO UNICENTRIC HIGH GRADE GLIOMA (UCHGG), IN A MIDWEST REGIONAL CANCER CENTER SERVING A RURAL OUTREACH AREA, WHICH DRAWS FROM A 100 MILE RADIUS
RADT-11. HIGH INCIDENCE AND OUTCOME OF MULTICENTRIC HIGH GRADE GLIOMA (MCHGG) COMPARED TO UNICENTRIC HIGH GRADE GLIOMA (UCHGG), IN A MIDWEST REGIONAL CANCER CENTER SERVING A RURAL OUTREACH AREA, WHICH DRAWS FROM A 100 MILE RADIUS Open
A retrospective review was conducted on patients diagnosed with high grade glioma between January 2022 and January 2025. Patient demographics including age, gender, geographic area, number of discrete lesions, molecular alterations includi…
View article: Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomas
Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomas Open
The limited success of immune checkpoint inhibitors (ICIs) in the adjuvant setting for glioblastoma highlights the need to explore administering ICIs prior to immunosuppressive radiation. To address the feasibility and safety of this appro…
View article: CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA
CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA Open
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. External beam radiation therapy (EBRT) is widely recognized as an effective treatment for primary GBM. EBRT applied after GBM resection is associated with an increas…